MC
GEHC icon

Mathes Company’s GE HealthCare GEHC Stock Holding History

Mathes Company’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.67M Sell
41,667
-1,186
-3% -$78K 0.83% 35
2026
Q1 		$3.05M Sell
42,853
-80
-0.2% -$6.31K 1.11% 28
2025
Q4 		$3.52M Sell
42,933
-4,421
-9% -$344K 1.26% 24
2025
Q3 		$3.56M Buy
47,354
+907
+2% +$67.7K 1.28% 24
2025
Q2 		$3.44M Sell
46,447
-1,081
-2% -$75.3K 1.28% 25
2025
Q1 		$3.84M Sell
47,528
-643
-1% -$55.3K 1.56% 25
2024
Q4 		$3.77M Sell
48,171
-1,080
-2% -$91.8K 1.37% 26
2024
Q3 		$4.62M Buy
49,251
+32,665
+197% +$2.74M 1.63% 21
2024
Q2 		$1.29M Buy
16,586
+1,416
+9% +$115K 0.47% 54
2024
Q1 		$1.38M Sell
15,170
-97
-0.6% -$8.07K 0.52% 51
2023
Q4 		$1.18M Buy
15,267
+50
+0.3% +$3.5K 0.49% 55
2023
Q3 		$1.03M Buy
15,217
+4,487
+42% +$326K 0.48% 57
2023
Q2 		$872K Buy
+10,730
New +$856K 0.38% 61

Other funds holding GEHC

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Mathes Company's GEHC Position: Q2 2026 in Review

Mathes Company reduced its GE HealthCare (GEHC) stake by 2.8% in Q2 2026, selling an estimated $78K and leaving 41,667 shares worth $2.67M. The position accounts for 0.83% of the portfolio, ranked #35.

Mathes Company first reported a position in GEHC in Q2 2023 and has held it in 13 quarters since. The position peaked at $4.62M in Q3 2024. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Mathes Company held 41,667 shares of GE HealthCare worth $2.67M as of Q2 2026.
  • Mathes Company sold 1,186 GE HealthCare shares in Q2 2026, an estimated $78K.
  • GE HealthCare made up 0.83% of Mathes Company's portfolio in Q2 2026, its #35 holding.
  • Mathes Company first reported a position in GE HealthCare in Q2 2023 and has held it in 13 quarters since.
  • Mathes Company's GE HealthCare position peaked at $4.62M in Q3 2024.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Mathes Company's 13F filing for Q2 2026, filed 11 Aug 2026.